Roche Holding AG (RHHBF)

USD 303.32

(0.0%)

Total Liabilities Summary of Roche Holding AG

  • Roche Holding AG's latest annual total liabilities in 2023 was 57.2 Billion CHF , up 1.9% from previous year.
  • Roche Holding AG's latest quarterly total liabilities in 2024 Q1 was 62.91 Billion CHF , up 9.97% from previous quarter.
  • Roche Holding AG reported annual total liabilities of 56.13 Billion CHF in 2022, down -12.25% from previous year.
  • Roche Holding AG reported annual total liabilities of 63.97 Billion CHF in 2021, up 37.97% from previous year.
  • Roche Holding AG reported quarterly total liabilities of 62.91 Billion CHF for 2024 Q1, up 9.97% from previous quarter.
  • Roche Holding AG reported quarterly total liabilities of 54.02 Billion CHF for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Roche Holding AG (2023 - 1998)

Historical Annual Total Liabilities of Roche Holding AG (2023 - 1998)

Year Total Liabilities Total Liabilities Growth
2023 57.2 Billion CHF 1.9%
2022 56.13 Billion CHF -12.25%
2021 63.97 Billion CHF 37.97%
2020 46.36 Billion CHF -1.82%
2019 47.22 Billion CHF -1.93%
2018 48.15 Billion CHF 1.01%
2017 47.66 Billion CHF -5.45%
2016 50.41 Billion CHF -3.9%
2015 52.46 Billion CHF -3.0%
2014 54.08 Billion CHF 32.15%
2013 40.92 Billion CHF -14.87%
2012 48.07 Billion CHF 2.09%
2011 47.09 Billion CHF -4.59%
2010 49.35 Billion CHF -24.24%
2009 65.15 Billion CHF 192.59%
2008 22.26 Billion CHF -10.49%
2007 24.87 Billion CHF -9.87%
2006 27.6 Billion CHF -0.08%
2005 27.62 Billion CHF 11.46%
2004 24.78 Billion CHF -18.27%
2003 30.32 Billion CHF -20.67%
2002 38.22 Billion CHF -7.72%
2001 41.41 Billion CHF 10.45%
2000 37.49 Billion CHF -7.25%
1999 40.43 Billion CHF 22.28%
1998 33.06 Billion CHF 0.0%

Peer Total Liabilities Comparison of Roche Holding AG

Name Total Liabilities Total Liabilities Difference
AstraZeneca PLC 61.86 Billion USD 7.533%
Bristol-Myers Squibb Company PFD CONV 2 65.67 Billion USD 12.896%
CSPC Pharmaceutical Group Limited 1.53 Billion USD -3615.06%
Clarus Therapeutics Holdings, Inc. 67.62 Million USD -84488.996%
Novartis AG 53.19 Billion USD -7.538%
PT Kalbe Farma Tbk. 255.94 Million USD -22250.898%